ArticleCureus2025
A Durable Response in Sinonasal Undifferentiated Carcinoma Treated With Subtotal Resection and Ultra-Early Postoperative Chemoradiotherapy: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sinonasal undifferentiated carcinoma (SNUC) is a rare and aggressive malignancy that arises in the nasal cavity and paranasal sinuses. Although gross total resection (GTR) is associated with improved local control and survival, the anatomical complexity and frequent skull base invasion often render complete resection infeasible. In such cases, the timing of postoperative therapy may be critical for disease control. We report a case of a 68-year-old man with stage IV SNUC who underwent subtotal endoscopic resection, followed by ultra-early postoperative concurrent chemoradiotherapy (CCRT) initiated within one week of surgery. CCRT was delivered using intensity-modulated radiation therapy (IMRT) and cisplatin (CDDP). The patient achieved a complete response with no evidence of recurrence at six-year follow-up. This case underscores the potential for durable disease control through timely multimodal therapy in anatomically unresectable cases where GTR is not feasible. While GTR remains the optimal goal when achievable, early postoperative chemoradiotherapy may offer meaningful benefit in selected patients with subtotal resection. We discuss the significance of treatment timing, surgical extent, and multidisciplinary planning in the context of recent literature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.